Ergebnis für "Bad Blood" in Wirtschaft & Karriere

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.

Es ist der Börsenskandal des Jahrzehnts: Im Sommer des Jahres 2020 kollabiert das einstige DAX-Unternehmen und Fintech-Wunderkind Wirecard, nachdem Milliardenbeträge verschwunden sind und unauffindbar bleiben. Mitglieder des Vorstands sowie leitende Manager werden verhaftet. Schicht um Schicht enthüllt sich die Geschichte eines gigantischen Kriminalfalls. Wie gelang es dem Unternehmen über so viele Jahre, die Politik, die Börse und die Öffentlichkeit zu blenden? "Bad Company" liefert eine spektakuläre Innenansicht der Wirecard AG.

What went wrong with American business at the end of the 20th century? Until the spring of 2001, Enron epitomised the triumph of the New Economy. Feared by rivals, worshipped by investors, Enron seemingly could do no wrong. Its profits rose every year; its stock price surged ever upward; its leaders were hailed as visionaries. Then a young Fortune writer, Bethany McLean, wrote an article posing a simple question - how, exactly, does Enron make its money?

In this hilarious, fascinating and insightful expose, industry insider Peter Smith reveals the massive blunders and dodgy dealings taking place around the world as private companies and public-sector bodies buy goods and services. A recent report showed that over 90 per cent of procurement projects fail. So, why are so many billions wasted on ineptitude, mismanagement and, in some cases, fraud?